Smart Open Services for European Patients (epSOS)

epSOS stands for Smart Open Services for European Patients and focuses on Interoperable Patient Summaries and ePrescribing. It involves 27 beneficiaries from 12 EU-member states, including ministries of health, national competence centres and industry. The project will deliver and validate interoperable patients' summaries and ePrescription solutions, which will enable the exchange of data in a safe, secure and interoperable manner also across national borders. The solutions (applications/services) will be based on existing national systems.

Ensuring that such solutions meet user needs is one of the key challenges for epSOS. The involvement of all key stakeholders including health professionals, patients, insurers and other Member States which are not directly involved in the project, is key for the success of epSOS.

For further information, please visit:

Project co-ordinator:
The Swedish association of local authorities and regions

Partners:
Austria, Belgium, Czech Republic, Germany, Denmark, France, Greece, Italy, the Netherlands, Spain, Slovakia, Sweden and the United Kingdom

Duration: 36 months

Total cost: € 23.000.000

Programme Acronym: ICT Policy Support programme under the Competitiveness and Innovation Framework Programme (CIP)

Related news articles:

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Researchers Use AI to Predict Cancer Ris…

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...